Cargando…
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
The Clostridium difficile toxins A and B are primarily responsible for symptoms of C. difficile associated disease and are prime targets for vaccine development. We describe a plasmid-based system for the production of genetically modified toxins in a non-sporulating strain of C. difficile that lack...
Autores principales: | Donald, Robert G. K., Flint, Mike, Kalyan, Narender, Johnson, Erik, Witko, Susan E., Kotash, Cheryl, Zhao, Ping, Megati, Shakuntala, Yurgelonis, Irina, Lee, Phillip Kwok, Matsuka, Yury V., Severina, Elena, Deatly, Anne, Sidhu, Mini, Jansen, Kathrin U., Minton, Nigel P., Anderson, Annaliesa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for General Microbiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749728/ https://www.ncbi.nlm.nih.gov/pubmed/23629868 http://dx.doi.org/10.1099/mic.0.066712-0 |
Ejemplares similares
-
Development of a subunit vaccine for prevention of Clostridium difficile associated diseases: Biophysical characterization of toxoids A and B
por: Gribenko, Alexey, et al.
Publicado: (2017) -
Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
por: Matsuoka, Osamu, et al.
Publicado: (2017) -
Phosphorylation and functionality of CdtR in Clostridium difficile
por: Bilverstone, T.W., et al.
Publicado: (2019) -
Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting
por: Quemeneur, Laurence, et al.
Publicado: (2018) -
Synthetic co‐culture of autotrophic Clostridium carboxidivorans and chain elongating Clostridium kluyveri monitored by flow cytometry
por: Bäumler, Miriam, et al.
Publicado: (2021)